- Home
- IKT vs MRAM Comparison
IKT vs MRAM Comparison
Compare IKT & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- MRAM
- Stock Information
- Founded
- IKT 2008
- MRAM 2008
- Country
- IKT United States
- MRAM United States
- Employees
- IKT N/A
- MRAM N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- MRAM Semiconductors
- Sector
- IKT Health Care
- MRAM Technology
- Exchange
- IKT Nasdaq
- MRAM Nasdaq
- Market Cap
- IKT 131.6M
- MRAM 114.4M
- IPO Year
- IKT 2020
- MRAM 2016
- Fundamental
- Price
- IKT $1.66
- MRAM $6.02
- Analyst Decision
- IKT Buy
- MRAM Strong Buy
- Analyst Count
- IKT 2
- MRAM 1
- Target Price
- IKT $8.00
- MRAM $8.00
- AVG Volume (30 Days)
- IKT 126.7K
- MRAM 92.8K
- Earning Date
- IKT 08-13-2025
- MRAM 07-30-2025
- Dividend Yield
- IKT N/A
- MRAM N/A
- EPS Growth
- IKT N/A
- MRAM N/A
- EPS
- IKT N/A
- MRAM N/A
- Revenue
- IKT N/A
- MRAM $49,110,000.00
- Revenue This Year
- IKT N/A
- MRAM $9.48
- Revenue Next Year
- IKT N/A
- MRAM $12.85
- P/E Ratio
- IKT N/A
- MRAM N/A
- Revenue Growth
- IKT N/A
- MRAM N/A
- 52 Week Low
- IKT $1.12
- MRAM $4.34
- 52 Week High
- IKT $4.20
- MRAM $7.00
- Technical
- Relative Strength Index (RSI)
- IKT 35.43
- MRAM 54.52
- Support Level
- IKT $1.91
- MRAM $5.70
- Resistance Level
- IKT $2.07
- MRAM $6.17
- Average True Range (ATR)
- IKT 0.11
- MRAM 0.22
- MACD
- IKT -0.03
- MRAM -0.00
- Stochastic Oscillator
- IKT 0.00
- MRAM 76.75
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).